CLASS II Device recall · Reported 13 Jan 2016 · FDA Enforcement Report

Siemens Acute Care pBNP TestPak recalled

Siemens Healthcare Diagnostics is recalling Siemens Acute Care pBNP TestPak- in vitro diagnostic test for the quantitative, distributed nationwide in the US. The recall was initiated on 11 Nov 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Numbers: 215166002, 215194002, 215222002, 215271002
Quantity recalled1157

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0610-2016
FDA event ID
72570
Recalling firm
Siemens Healthcare Diagnostics, Norwood, MA
Classification
Class II
Status
Terminated
Recall initiated
11 Nov 2015
FDA classified
7 Jan 2016
Reported
13 Jan 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

11 Nov 2015Recall initiated by company
7 Jan 2016Classified by FDA+57 days
13 Jan 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Stratus CS Cartridge Barcode labels may not scan on the Stratus CS systems

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Siemens Acute Care pBNP TestPak- in vitro diagnostic test for the quantitative measurement of N-terminal pro-brain natriuretic peptide (NTproBNP) in heparinized plasma. Catalog Number: CPBNPM SMN: 10445086

Where it was distributed

Worldwide Distribution - US (nationwide), Algeria, Armenia, Australia, Austria, Bangladesh, Bosnia Herzegovina, Canada, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Japan, Libya, Malaysia, Poland, Portugal, Romania, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, U.A.E., and United Kingdom.

Nationwide

Questions about this recall

Is Siemens Acute Care pBNP TestPak- in vitro diagnostic test for the quantitative recalled?

Yes. Siemens Healthcare Diagnostics recalled Siemens Acute Care pBNP TestPak- in vitro diagnostic test for the quantitative on 11 Nov 2015. The recall is Class II and its status is Terminated. Recall number Z-0610-2016.

Why was it recalled?

Stratus CS Cartridge Barcode labels may not scan on the Stratus CS systems

Which lots are affected?

Lot Numbers: 215166002, 215194002, 215222002, 215271002

Where was it sold?

Worldwide Distribution - US (nationwide), Algeria, Armenia, Australia, Austria, Bangladesh, Bosnia Herzegovina, Canada, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Japan, Libya, Malaysia, Poland, Portugal, Romania, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, U.A.E., and United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Test Kits & Diagnostics recalls

All 2,656